1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department...
-
Upload
godwin-chandler -
Category
Documents
-
view
219 -
download
3
Transcript of 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department...
![Page 1: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/1.jpg)
1
Clinical Aspects of Stroke
Pierre Fayad, MDReynolds Centennial Professor & Chairman,
Department of Neurological Sciences
University of Nebraska Medical Center, Omaha, NE
![Page 2: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/2.jpg)
2
“Stroke”
• APOPLEXY from Greek “Apo Plexe” meaning “a stroke”.
• Anyone seized by sudden disability was thought to be “struck down” by the Gods.
Haubrich WS. Medical Meanings: A Glossary of Word Origins. Publisher: American College of Physicians 2003
![Page 3: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/3.jpg)
3
Steps in Neurologic Evaluation
Gather information– Chief complaint– Symptoms, evolution– Physical examination
Analysis– Localization– Pattern of disease– Comparison to clinical database
Gather information– Diagnostic tests
Diagnosis & Treatment
![Page 4: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/4.jpg)
4
Steps in Stroke EvaluationGather information
– Chief complaint– Symptoms and history: risk factors, chronologic
evolution– Physical examination: vascular and neurologic
Analysis– Localization: CNS level, large vessel, branch, …– Pattern of disease: tempo, risk factors– Comparison to clinical datatbase
Gather information– Diagnostic tests: location, size, type, mechanism
Diagnosis & Treatment
![Page 5: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/5.jpg)
7
What Is A “STROKE”?
CLINICAL DEFINITION of focal neurologic deficit, of vascular etiology, lasting > 24 HOURS.
Diagnosis is dependent on neurologic deficit and NOT imaging.
“Generic term for a clinical syndrome that includes infarction, hemorrhage, and SAH.”
NINDS Classification of CVD III. Stroke 1990, 20:627-680
![Page 6: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/6.jpg)
8
Types of Stroke
• Ischemic Stroke– Brain damage from lack of blood flow– Occlusion of blood vessel– Thrombosis, embolism
• Hemorrhagic stroke– Rupture of blood vessel– Brain damage from blood invasion
![Page 7: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/7.jpg)
9
Stroke Subtypes: Stroke Data Bank
Lacunar19%
SAH13%
ICH13%
Other3%
Cardioembolic14%
Atherosclerotic6%
Undetermined32%
Stroke Data Bank, Foulkes et al, Stroke 1988;19:547
![Page 8: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/8.jpg)
10
Definition of Transient Ischemic Attack• Classic definition
– A sudden, focal neurologic deficit lasting less than 24 hours, presumed to be of vascular origin, and confined to an area of the brain or eye perfused by a specific artery
• Proposed definition– A brief episode of neurologic dysfunction caused by
focal brain or retinal ischemia, with clinical symptoms typically lasting less than 1 hour, and without evidence of acute infarction
Albers GW et al. N Engl J Med. 2002;347:1713-1716.
![Page 9: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/9.jpg)
11
Short-term Prognosis after Emergency Department Diagnosis of TIA
Johnston SC, et al. JAMA 2000;284:2901-2906.
Inclusion criteria:
Objective:
Outcome measures:
Total events:
TIA by ED physicians
Short-term risk of strokeafter ED diagnosis
Risk of stroke and otherevents during the 90 daysafter index TIA
25.1%
Outcome events
10.5%
12.7%
2.6% 2.6%
Stroke RecurrentTIA
CV event Death
0 %
5 %
10 %
15 %
Within90 days
Within48 hr
5.3%
![Page 10: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/10.jpg)
12
US Stroke Facts 2003• Incidence
– 700,000 new or recurrent stroke yearly– One stroke every 45 seconds
• Mortality– 168,000 Stroke-related death yearly (1 of 14 deaths)– Third leading cause of death after heart and cancer– One stroke-related death every 3 minutes– Of every 5 stroke deaths: 2 men, 3 women
• Costs– $51 billion in 2003 for stroke related medical costs and
disability
American Stroke Association
![Page 11: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/11.jpg)
13
Stroke Risk Factors
Medical Conditions Hypertension Cardiac disease Atrial fibrillation Hyperlipidemia Diabetes mellitus Carotid stenosis Prior TIA or stroke
Non-Modifiable
Age, Gender, Race, Heredity
Behaviors Cigarette smoking Heavy alcohol use Physical inactivity
Modifiable
![Page 12: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/12.jpg)
14
Goals For Acute Stroke Care• Rapid triage and identification of stroke
• Stroke type: Ischemic vs Hemorrhagic• Eligibility for “acute stroke therapy”• Determine size, location, & vascular territory• Establish plans for efficient Management &
discharge• Stabilization & prevention of complications• Determine etiology & mechanism• Initiate secondary stroke prevention strategies• Initiate rehabilitation assessment and therapy
![Page 13: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/13.jpg)
15
Intracerebral Hemorrhage
![Page 14: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/14.jpg)
16
Hypertensive ICH: Post-Mortem
![Page 15: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/15.jpg)
17
Clinical Features Suggestive Of ICH
• Severe headache
• Depressed consciousness
• Nausea and vomiting
• Horizontal diplopia
• Papilledema and pre-retinal hemorrhages.
![Page 16: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/16.jpg)
18
ICHSx
![Page 17: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/17.jpg)
19
CAUSES OF INTRACRANIAL HEMORRHAGE
HTNHTN50%50%Amyloid angiopathyAmyloid angiopathy12%12%AnticoagulantsAnticoagulants10%10%TumorsTumors 8%8%Prescription and street drugsPrescription and street drugs 6%6%AVMs and aneurysmsAVMs and aneurysms 5%5%MiscellaneousMiscellaneous 9%9%
![Page 18: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/18.jpg)
20
Charcot-Bouchard Microaneurysms
![Page 19: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/19.jpg)
21
Intracranial Vascular Malformations
![Page 20: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/20.jpg)
22
ICH - General Management
• Nutrition• DVT prophylaxis• Hydration and electrolytes• Acute arterial hypertension• Intracranial hypertension• Hydrocephalus• Seizure prophylaxis and treatment• Surgery and decompression
AHA Special Writing Group, Stroke 1999;30:905-915AHA Special Writing Group, Stroke 1999;30:905-915
![Page 21: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/21.jpg)
23
Dose-Ranging Study: rFVIIa in Preventing Early Hematoma Growth in Acute ICH
• Multicenter, international, Phase II study, 400 patients, CT < 3 hrs from Sx, Rx < 60 min CT.
• Arms: Placebo, 40, 80, 160 mcg/kg• Significantly reduces
– 45-62% RR Dose-dependent hematoma growth– 38% RR Mortality
• Significantly improves– Global functional outcome (mRS and BI) at 90 days
• Small increase in the risk of acute thromboembolic events
Mayer SA et al. N Engl J Med. 2005;352:777-785.
![Page 22: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/22.jpg)
24
Subarachnoid Hemorrhage
![Page 23: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/23.jpg)
25
Subarachnoid Hemorrhage: Schematic
![Page 24: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/24.jpg)
26
Berry Aneurysm Rupture
![Page 25: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/25.jpg)
27
Location of Berry Aneurysms
![Page 26: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/26.jpg)
28
SAH Symptoms
& Diagnosis
![Page 27: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/27.jpg)
29
IntracranialAneurysms Sx
![Page 28: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/28.jpg)
31Johnston SC, et al. Ann Neurol. 2000;48:11-19.
Aneurysm Coiling or Clipping
![Page 29: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/29.jpg)
32
SAH - Delayed Vasospasm• Facts
– A leading cause of death and disability
– Starts 3-5 d after SAH, and maximal at 3-14 d.
– 20-30% delayed neurologic ischemic deficits.
• Diagnosis – TCD, angiography.
• Treatment– Nimodipine
– Hypertensive, hypervolemic, hyperosmolar Rx (HHH)
– Local IA papaverine -> transluminal angioplasty
![Page 30: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/30.jpg)
33
Ischemic Stroke
![Page 31: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/31.jpg)
34
Stroke Mimics• Metabolic
–Hyper/hypoglycemia, Hyponatremia, Hypo/hyperthyroidism, Hepatic encephalopathy
• Seizures• Subdural hematoma• Infections
–Brain abscess, encephalitis, meningitis
• Neoplasm• Drug overdose (also a cause of stroke).• Hypertensive encephalopathy• Psychogenic• Migraine
![Page 32: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/32.jpg)
35
Vascular Localization
![Page 33: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/33.jpg)
36
!!!Learn Neurology Stroke-By-Stroke!!!
![Page 34: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/34.jpg)
37
Brain Picture
![Page 35: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/35.jpg)
38
What The Brain Does
![Page 36: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/36.jpg)
39
Cortical Functional Localization
![Page 37: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/37.jpg)
40
Homunculus
![Page 38: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/38.jpg)
41
Localizing Stroke
• Stroke affects three main areas of the brain
–Left hemisphere
–Right hemisphere
–Brainstem/cerebellum
• Neurologic deficits patterned in syndromes according to brain part affected and location
![Page 39: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/39.jpg)
42
Cerebral Circulation
![Page 40: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/40.jpg)
43
Cerebral Vascular Territories
![Page 41: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/41.jpg)
44
Left (Dominant) Cerebral Hemisphere Syndrome
• Aphasia.
• Left gaze preference.
• Right visual field cut.
• Right hemiparesis.
• RIght hemisensory loss.
![Page 42: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/42.jpg)
45
Right (Non-dominant) Cerebral Hemispheric Syndrome
• Neglect (left hemi-inattention)
• Right gaze preference.
• Left visual field deficit.
• Left hemiparesis.
• Left hemisensory loss.
![Page 43: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/43.jpg)
47
Syndromes of Carotid Branch Occlusions
Location
Frontal Lobe
Parietal lobe
Temporal lobe
Occipital lobe
Artery
ACA
MCA: ant division
MCA: post division
MCA: post division
PCA
Dominant Non-dominant
Contralat LE weaknessAbulia
Contralat LE weaknessAbulia
Expressive aphasiaContralat hemiparesisIpsilat gaze deviation
AprosodiaContralat hemiparesisIpsilat gaze deviation
Conduction aphasiaGerstman’s synd, HH Contral hypoesthesia
Anosognosia, Apraxia, Contralateral neglect, Hypoesthesia, HH
Receptive aphasia, Contralateral HH
Contralateral Hemianopia
Alexia without agraphiaContralateral HH
Contralateral Hemianopia
![Page 44: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/44.jpg)
48
Brainstem Syndrome
• Crossed signs.
• Hemiparesis or quadraparesis.
• Hemisensory loss or sensory loss in all four limbs.
• Eye movement abnormalities.
• Oropharyngeal weakness.
• Decreased consciousness.
• Hiccups or abnormal respirations.
![Page 45: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/45.jpg)
49
Cerebellar Syndrome
• Gait or limb ataxia
• Vertigo, tinnitus
• Nausea, vomiting.
• Decreased Consciousness.
![Page 46: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/46.jpg)
50
Acute Stroke Therapy
![Page 47: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/47.jpg)
51
Platelets in Acute Vascular Events
AtheroscleroticVessel
PlaqueRupture
PlateletAdhesion,
Recruitment,Activation,
andAggregation
ThrombusFormation
ThromboticOcclusion
MI
Stroke
Acute Peripheral Arterial Occlusion
CollagenPlaquePlatelets Thrombus
![Page 48: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/48.jpg)
52
Cerebral Ischemia: Basic Mechanisms
•Perfusion failure•Energy failure•Loss of membrane function•Edema•Cell death
![Page 49: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/49.jpg)
53
Ischemic Cascade
QuickTime™ and aPhoto - JPEG decompressor
are needed to see this picture.
Brott T et al, NEJM 2000,343:710-721
![Page 50: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/50.jpg)
54
ISCHEMIC PENUMBRA
![Page 51: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/51.jpg)
55
Acute Ischemic Stroke: Large MCA, CT
![Page 52: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/52.jpg)
56Time is Brain
![Page 53: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/53.jpg)
58
Supportive Acute Stroke Care
• Monitor for potential worsening
• Stabilize vital signs
• Maintain adequate hydration
• Optimize nutrition: early, PO, NG feeds, PEG
• Prevent aspiration: screen for those at risk
• Treat fever aggressively: any elevations
• Mobilize early: within 24 hours
![Page 54: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/54.jpg)
59
Therapies for Acute Cerebral Ischemia
• Antithrombotic therapy– Antiplatelet medications
– Aspirin, Clopidogrel, ASA/ER-DP– IV GP IIb IIIa antagonists (Abciximab)
– Anticoagulants – Hypofibrinogenemic (Ancrod)
• Reperfusion and perfusion enhancement– Thrombolytic therapy: Intravenous, intra-Arterial– Mechanical clot dissolution/removal
• Neuroprotective Therapies– Non-specific cellular protection– Specific neuronal protection
![Page 55: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/55.jpg)
60
Acute Antiplatelet Therapy for Stroke
• Aspirin 160 mg daily, started within 48 hours, decreases risk of stroke and death at one month.
• Other antiplatelet agents not tested acutely.
• As a rule early AP Rx start recommended.
• Preferable to start same AP agent as OP.
CAST Collaborative Group, Lancet 1997;349:1641-1649
![Page 56: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/56.jpg)
61
Acute Anticoagulation For Stroke: Conclusions
• Acute anticoagulation DOES NOT…– Does not improve overall outcome, prevent neurologic deterioration or
prevent recurrence
• Indications– SQ anticoagulation for DVT prophylaxis in immobilized patients or
paralyzed leg
– Sinus venous thrombosis
• Risks– Risk of cerebral hemorrhage and systemic bleed substantially
increased.
• Untested– Acute anticoagulation < 12 hours
![Page 57: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/57.jpg)
62
NINDS IV tPA
Primary Outcomes
NEJM 1995;333:1581-1587
![Page 58: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/58.jpg)
63
Acute Stroke: Intra-Arterial Lysis
Brott T et al, NEJM 2000,343:710-721
![Page 59: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/59.jpg)
64
Merci Clot Retriever Concentric Medical Inc.
Gobain YP. Stroke 2004;35:2848-2854
![Page 60: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/60.jpg)
65
MERCI-1: Example of Clots Retrieved
Gobain YP. Stroke 2004;35:2848-2854
![Page 61: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/61.jpg)
66
Stroke Prevention Strategies
• Identify stroke subtype and mechanism
• Risk Factors and Lifestyle modification
• Non-Anti-thrombotic Treatments
• Oral Anticoagulation
• Antiplatelet Medications
• Surgery and interventions
![Page 62: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/62.jpg)
67
Stroke Mechanism Determination
CT/MRI
Hemorrhagic StrokeHemorrhagic Stroke
Ischemic StrokeIschemic Stroke
Large Artery StrokeLarge Artery Stroke
Cardioembolic Stroke Cardioembolic Stroke
Lacunar syndrome, YesRisk Factors
No Lacunar small vessel Lacunar small vessel
stroke stroke
Other defined etiologies, YesNo
Infarct undetermined Infarct undetermined causecause
other
TIA or Stroke normal or infarct
Specific work-up
Tandem pathology, YesNo
TTE/TEE, ECGcardiac source, Yes
No
Infarction Determined Infarction Determined EtiologyEtiology
Duplex, TCD, MRA, angiogram
blood
Adapted Fayad PB; J. Cardiovascular Diagn & Proc 1994;12 (1):35-42.
![Page 63: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/63.jpg)
68
Carotid Bifurcation Athero-Thrombo-Embolism
![Page 64: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/64.jpg)
69
MCA Embolism
![Page 65: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/65.jpg)
70
Common Cardioembolic
Sources
![Page 66: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/66.jpg)
71
Intracranial Atherothrombosis
![Page 67: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/67.jpg)
72
Lenticulostriate Arteries
![Page 68: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/68.jpg)
73
Classic Lacunar SyndromesClinical features Common locationsLacunar Syndrome
Hemiparesis (arm, leg, face equally)
Post limb IC, Ant limb IC, Corona radiata
Sensory loss, dysesthesia (face, arm, leg)
Thalamus, centrum semiovale
Combined hemi motor and sensory deficits
Thalamus, putamen, corona radiata
Homolateral ataxia with crural paresis
Corona radiata, posterior limb IC, thalamus
Combined dysarthria, upper limb ataxia
Anterior limb IC, genu, pons hemorrhage
Pure motor hemiparesis
Pure sensory stroke
Sensory-motor stroke
Ataxic hemiparesis
Dysarthria-clumsy hand syndrome
Fayad et al. Curr. Rev CVD 1996, Current Medicine: 81-92
![Page 69: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/69.jpg)
74
CarotidPathologies
![Page 70: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/70.jpg)
75
Non Anti-Thrombotic Treatments
![Page 71: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/71.jpg)
76
Non-Anti-Thrombotic Medical Therapies For Stroke Prevention-1: Lipid Lowering
• Clear benefit for statins in primary stroke prevention (20-30%) in patients with CAD and even average level of LDL cholesterol.
• No demonstration yet of statin benefit in secondary stroke risk reduction. (Exception HSP, SPARCL pending).
![Page 72: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/72.jpg)
77
Non-Anti-Thrombotic Medical Therapies For Stroke Prevention-2: Anti-HTN
• Significant stroke risk reduction (20%-30% RRR ischemic, >50% RRR hemorrhagic) in treating hypertension, systolic or diastolic. (more evidence for systolic)
• Anti-HTN: Significant primary & stroke risk reduction, even in non-hypertensives.
• Superiority of Anti-HTN drug classes in stroke prevention undetermined yet.
![Page 73: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/73.jpg)
78
Non-Anti-Thrombotic Medical Therapies For Stroke Prevention-3: Miscellaneous
• No benefit (but clear harm) from hormonal replacement in post-menopausal women.
• No benefit from Vitamin B supplementation in hyperhomocystinemia in patients with stroke or TIA.
![Page 74: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/74.jpg)
79
Antiplatelet (AP) Therapy in Stroke Prevention: Summary
• Aspirin (ASA) not indicated for primary stroke prevention.
• Low-dose ASA recommended for secondary stroke prevention.
• No single AP agent more effective than aspirin.• To Date, ASA-ER DP only AP combination
effective and safe (> ASA) in secondary stroke prevention
• In patients at risk for stroke, the combination of Clopidogrel and aspirin significantly increase the risk of ICH, life-threatening and major bleeding.
![Page 75: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/75.jpg)
80
AsymptomaticICA/CCA stenosis
Risk factormodification
Warfarin
Asymptomatic and healthywithout risk factors
AntiplateletAnti-HTN?Statins?
Men> 60
Women post-menopausal
Estrogen
Asymptomatic butwith risk factors
NVAFCardioembolic
source/pathology
Endarterectomy
Evaluate CAD
No other pathology
Primary Prevention Of Ischemic Stroke
Adapted From Fayad PB; J. Cardiovascular Diagn & Proc 1994;12 (1):35-42.
AMI
Statins
High riskLow risk
X
![Page 76: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/76.jpg)
81
Secondary Prevention of Ischemic Stroke
Adapted From Fayad PB; J. Cardiovascular Diagn & Proc 1994;12 (1):35-42.
Extracranialcarotid stenosis
70-99%
TIA or STROKE
Cardiogenic embolism
Small VesselLacunar
Undeterminedetiology
CEA
50-69% < 50%
Intra/extra-cranialstenosis/occlusion
Large Vessel Athero
Documentedsource/pathology
AF
Antiplatelet, EstrogenAnti-HTN? Statins?
WarfarinXXXX
![Page 77: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/77.jpg)
82
Carotid Stenting
Reimers B, et al. Circulation. 2001;104:12-15.
![Page 78: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/78.jpg)
83
ACCULINK & ACCUNET Stent System (Guidant): ARCHER & CREST
ACCULINK ACCUNET
![Page 79: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/79.jpg)
85
Cerebral Circulation
![Page 80: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/80.jpg)
86
72-year-old right-handed African-American woman
admitted with weakness and speech difficulty
Stroke Case
![Page 81: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/81.jpg)
87
Stroke Case:
• Sudden onset of right arm and leg weakness• Speech difficulty• Hospital admission ~6 h after symptom onset
72-year-old woman
Presentation
• Hypertension• Dyslipidemia• Diabetes• Nonsmoker• Rarely drinks alcohol
History
![Page 82: 1 Clinical Aspects of Stroke Pierre Fayad, MD Reynolds Centennial Professor & Chairman, Department of Neurological Sciences University of Nebraska Medical.](https://reader036.fdocuments.us/reader036/viewer/2022062321/56649e305503460f94b205a1/html5/thumbnails/82.jpg)
88
CT scan at 10 days
Stroke Case:72-year-old woman
Should this patient have had a follow-up scan earlier than 10 days post-admission?
Would an MRI have been better?